tiprankstipranks
Quanterix Corporation (QTRX)
NASDAQ:QTRX
US Market
Holding QTRX?
Track your performance easily

Quanterix (QTRX) Earnings Dates, Call Summary & Reports

342 Followers

Earnings Data

Report Date
Mar 17, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-0.25
Last Year’s EPS
-0.33
Same Quarter Last Year
Based on 4 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 01, 2018
|
% Change Since: -41.53%
|
Next Earnings Date:Aug 08, 2018
Earnings Call Sentiment|Positive
The earnings call highlights Quanterix's consistent revenue growth and strategic advancements in Alzheimer's diagnostics, despite challenges with instrument sales and financial restatements. The company's strong liquidity position and expansion in product offerings reinforce a positive outlook.
Company Guidance
During the Q3 2024 earnings call for Quanterix Corporation, the company reaffirmed its guidance, projecting full-year revenue between $134 million and $138 million, indicating an 11% growth at the midpoint. The preliminary non-GAAP gross margin for the third quarter was reported at 53.4%, reflecting a 160 basis point increase compared to the same period last year. Quanterix's revenues for the quarter reached $35.7 million, marking a 13% year-over-year growth, driven significantly by a 36% increase in Accelerator Lab revenue and an 8% rise in consumables sales. However, instrument revenue saw a decline of 39%. The company maintained a strong balance sheet with $296.1 million in liquidity and managed to reduce quarterly cash usage to $3 million. Quanterix continues to focus on expanding its product offerings, having commercialized 16 new products year-to-date with plans to launch four more assays by year-end. The company is also progressing in the field of Alzheimer's diagnostics, with its multi-marker assay, LucentAD Complete, showing promising results in reducing intermediate diagnostic zones.
Consistent Double-Digit Revenue Growth
Quanterix reported a sixth consecutive quarter of double-digit revenue growth with Q3 2024 revenue increasing by 13% to $35.7 million.
Strong Performance in Accelerator Lab
Accelerator Lab revenue increased by 36%, reaching $10.5 million, driven by clinical trials and custom assay development.
Significant Advances in Alzheimer's Disease Testing
Launch of LucentAD Complete, a multi-marker assay, showing strong interest and promising results in Alzheimer's diagnostics with accuracy above 90%.
Expansion of Product Portfolio
Commercialization of 16 new products year-to-date, with plans to launch 4 more assays by the end of the year.
Positive Cash and Liquidity Position
Nearly $300 million in liquidity with reduced cash usage to $3 million in the quarter.
---

Quanterix (QTRX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

QTRX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 08, 20182018 (Q2)
- / -0.34
-0.3738.85% (+0.03)
Nov 01, 20182018 (Q3)
- / -0.35
-0.3571.96% (<+0.01)
Mar 07, 20192018 (Q4)
- / -0.39
-0.34-14.71% (-0.05)
May 09, 20192019 (Q1)
- / -0.42
-0.33-27.27% (-0.09)
Aug 06, 20192019 (Q2)
- / -0.46
-0.34-35.29% (-0.12)
Nov 06, 20192019 (Q3)
- / -0.37
-0.35-5.71% (-0.02)
Mar 09, 20202019 (Q4)
- / -0.38
-0.392.56% (+0.01)
May 05, 20202020 (Q1)
- / -0.41
-0.422.38% (+0.01)
Aug 04, 20202020 (Q2)
- / -0.43
-0.466.52% (+0.03)
Nov 05, 20202020 (Q3)
- / 0.07
-0.37119.73% (+0.44)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

QTRX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2024$15.17$12.40-18.26%
Aug 08, 2024$12.82$10.92-14.82%
May 07, 2024$17.36$16.51-4.90%
Feb 29, 2024$23.96$27.00+12.69%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Quanterix Corporation (QTRX) report earnings?
Quanterix Corporation (QTRX) is schdueled to report earning on Mar 17, 2025, TBA Not Confirmed.
    What is Quanterix Corporation (QTRX) earnings time?
    Quanterix Corporation (QTRX) earnings time is at Mar 17, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is QTRX EPS forecast?
          QTRX EPS forecast for the fiscal quarter 2024 (Q4) is -0.25.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis